Literature DB >> 8665077

Indefinite survival of rat islet allografts following infusion of donor bone marrow without cytoablation.

C Ricordi1, N Murase, C Rastellini, R Behboo, A J Demetris, T E Starzl.   

Abstract

We have tested the effect of donor bone marrow cell (DBMC) infusion on the survival of pancreatic islet allografts in the rat, without the use of cytoablative recipient conditioning. Lewis and diabetic Brown Norway rats were used as donors and recipients, respectively. Donor islets were placed beneath the left renal capsule. Infusion of DBMC and temporary immunosuppression followed by delayed islet transplantation resulted in indefinite survival of all islet grafts (MST > 180 days). Control animals demonstrated recurrent hyperglycemia (islet allografts rejection). Donor bone marrow derived cells were detected in the spleen and cervical lymph nodes of BN recipients of LEW bone marrow but not in the recipients of islet transplants alone. Second set full thickness skin grafts were performed in normal BN and in recipients of a previously successful ITX. Donor specific skin grafts were accepted in the animals that had received DBMC 40 days before the islet allograft, while animals receiving DBMC at the time of the islet allograft rejected the donor specific skin graft similarly to the controls. However, these animals did not reject a second set donor-specific islet transplant. The results indicate that radiation conditioning of the recipients was not necessary to induce microchimerism and graft acceptance in this rodent model of islet allotransplantation.

Entities:  

Mesh:

Year:  1996        PMID: 8665077      PMCID: PMC2964070          DOI: 10.1177/096368979600500110

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.139


  7 in total

1.  Donor dendritic cell repopulation in recipients after rat-to-mouse bone-marrow transplantation.

Authors:  C Ricordi; S T Ildstad; A J Demetris; A Y Abou el-Ezz; N Murase; T E Starzl
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

2.  Islet xenografts in fully xenogeneic (rat----mouse) chimeras: evidence for normal regulation of function in a xenogeneic mouse environment.

Authors:  C Ricordi; Y Zeng; P B Carroll; H L Rilo; D R Beretier; T E Starzl; S T Ildstad
Journal:  Surgery       Date:  1992-08       Impact factor: 3.982

3.  Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation.

Authors:  A J Demetris; N Murase; S Fujisaki; J J Fung; A S Rao; T E Starzl
Journal:  Transplant Proc       Date:  1993-12       Impact factor: 1.066

4.  Competitive repopulation in unirradiated normal recipients.

Authors:  D E Harrison
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

5.  Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice.

Authors:  F M Stewart; R B Crittenden; P A Lowry; S Pearson-White; P J Quesenberry
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

6.  Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras (WF rat----B10 mouse).

Authors:  Y J Zeng; C Ricordi; A Tzakis; H L Rilo; P B Carroll; T E Starzl; S T Ildstad
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

7.  Mixed xenogeneic chimerism (mouse+rat-->mouse) to induce donor-specific tolerance to sequential or simultaneous islet xenografts.

Authors:  H Li; C Ricordi; A J Demetris; C L Kaufman; C Korbanic; M L Hronakes; S T Ildstad
Journal:  Transplantation       Date:  1994-02-27       Impact factor: 4.939

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.